The DOI matches its Crossref record; 129 of the 129 references it cites were found in a registry or an index.
Perfusion mammalian cell culture for recombinant protein manufacturing – A critical review
Open accessAbstract
The manufacturing of recombinant protein is traditionally divided in two main steps: upstream (cell culture and synthesis of the target protein) and downstream (purification and formulation of the protein into a drug substance or drug product). Today, cost pressure, market uncertainty and market growth, challenge the existing manufacturing technologies. Leaders in the field are active in designing the process of the future and continuous manufacturing is recurrently mentioned as a potential solution to address some of the current limitations. This review focuses on the application of continuous processing to the first step of the manufacturing process. Enabling technologies and operation modes are described in the first part. In the second part, recent advances in the field that have the potential to support its successful future development are critically discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Production of recombinant protein therapeutics in cultivated mammalian cells
Wurm, F. M. (2004) · Nature Biotechnology · doi:10.1038/nbt1026 · Cited by 2,032 · cited 2×
“…in constant evolution since the first biological drug manufactured in recombinant mammalian cells was commercialized in 1986 (Ecker et al., 2015; Wurm, 2004), a more profound mindset evolution is being discussed for some time among the scientific community: the transition of traditional batch…”
BackgroundThe therapeutic monoclonal antibody market
Ecker, D. M., Jones, S. D., & Levine, H. L. (2015) · mAbs · doi:10.4161/19420862.2015.989042 · Cited by 1,286
Biopharmaceutical benchmarks 2014
Walsh, G. (2014) · Nature Biotechnology · doi:10.1038/nbt.3040 · Cited by 1,008
GENETICS OF SOMATIC MAMMALIAN CELLS
Puck, T. T., Cieciura, S. J., & Robinson, A. (1958) · The Journal of Experimental Medicine · doi:10.1084/jem.108.6.945 · Cited by 960
Industrialization of mAb production technology: The bioprocessing industry at a crossroads
Kelley, B. (2009) · mAbs · doi:10.4161/mabs.1.5.9448 · Cited by 667
Industrial choices for protein production by large-scale cell culture
Chu, L., & Robinson, D. K. (2001) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(00)00197-x · Cited by 547
Animal‐cell culture media: History, characteristics, and current issues
Yao, T., & Asayama, Y. (2017) · Reproductive Medicine and Biology · doi:10.1002/rmb2.12024 · Cited by 536
Recombinant protein therapeutics from CHO cells : 20 years and counting
Jayapal, K. P., Wlaschin, K. F., Hu, W., & Yap, M. G. S. (2007) · Chemical engineering progress · Cited by 473
Integrated continuous production of recombinant therapeutic proteins
Warikoo, V., Godawat, R., Brower, K., Jain, S., Cummings, D., Simons, E., Johnson, T., Walther, J., Yu, M., Wright, B., et al. (2012) · Biotechnology and Bioengineering · doi:10.1002/bit.24584 · Cited by 422
Khawli, L. A., Goswami, S., Hutchinson, R., Kwong, Z. W., Yang, J., Wang, X., Yao, Z., Sreedhara, A., Cano, T., Tesar, D. B., et al. (2010) · mAbs · doi:10.4161/mabs.2.6.13333 · Cited by 419
Mehling, M., & Tay, S. (2014) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2013.10.005 · Cited by 390
Expression of recombinant plasmids in mammalian cells Is enhanced by sodium butyrate
Gorman, C. M., Howard, B. H., & Reeves, R. (1983) · Nucleic Acids Research · doi:10.1093/nar/11.21.7631 · Cited by 367
Abu‐Absi, N. R., Kenty, B. M., Cuellar, M. E., Borys, M. C., Sakhamuri, S., Strachan, D. J., Hausladen, M. C., & Li, Z. J. (2011) · Biotechnology and Bioengineering · doi:10.1002/bit.23023 · Cited by 322 · cited 1×
“Process parameters such as glucose, glutamate, glutamine, lactate and ammonium concentrations, total cell density (TCD), and viable cell density were monitored in fed-batch processes (Abu-Absi et al., 2011; Whelan et al., 2012).”
MethodWhite Paper on Continuous Bioprocessing May 20–21 2014 Continuous Manufacturing Symposium
Konstantinov, K. B., & Cooney, C. L. (2015) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24268 · Cited by 306
Pollock, J., Ho, S. V., & Farid, S. S. (2013) · Biotechnology and Bioengineering · doi:10.1002/bit.24608 · Cited by 291
Influence of low temperature on productivity, proteome and protein phosphorylation of CHO cells
Kaufmann, H., Mazur, X., Fussenegger, M., & Bailey, J. E. (1999) · Biotechnology and Bioengineering · doi:10.1002/(sici)1097-0290(19990605)63:5<573::aid-bit7>3.0.co;2-y · Cited by 278
Post-translational modifications of protein biopharmaceuticals
Walsh, G. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.06.009 · Cited by 263
Voisard, D., Meuwly, F., Ruffieux, P. ‐., Baer, G., & Kadouri, A. (2003) · Biotechnology and Bioengineering · doi:10.1002/bit.10629 · Cited by 261
Microtiter plates as mini-bioreactors: miniaturization of fermentation methods
Duetz, W. A. (2007) · Trends in Microbiology · doi:10.1016/j.tim.2007.09.004 · Cited by 244
Walther, J., Godawat, R., Hwang, C., Abe, Y., Sinclair, A., & Konstantinov, K. (2015) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2015.05.010 · Cited by 238
Eon‐Duval, A., Broly, H., & Gleixner, R. (2012) · Biotechnology Progress · doi:10.1002/btpr.1548 · Cited by 234
Self-citationThe future of industrial bioprocessing: Batch or continuous?
Croughan, M. S., Konstantinov, K. B., & Cooney, C. (2015) · Biotechnology and Bioengineering · doi:10.1002/bit.25529 · Cited by 234
Life and death in mammalian cell culture: strategies for apoptosis inhibition
Arden, N., & Betenbaugh, M. J. (2004) · Trends in Biotechnology · doi:10.1016/j.tibtech.2004.02.004 · Cited by 227
End-to-end integrated fully continuous production of recombinant monoclonal antibodies
Godawat, R., Konstantinov, K., Rohani, M., & Warikoo, V. (2015) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2015.06.393 · Cited by 226
Biomanufacturing: history and perspective
Zhang, Y.-H. P., Sun, J., & Ma, Y. (2017) · Journal of Industrial Microbiology and Biotechnology · doi:10.1007/s10295-016-1863-2 · Cited by 226
Real-time bioprocess monitoring
Vojinović, V., Cabral, J. M. S., & Fonseca, L. P. (2006) · Sensors and Actuators B: Chemical · doi:10.1016/j.snb.2005.07.059 · Cited by 221
Engineering challenges in high density cell culture systems
Ozturk, S. S. (1996) · Cytotechnology · doi:10.1007/bf00353919 · Cited by 200
Zhu, M. M., Goyal, A., Rank, D. L., Gupta, S. K., Boom, T. V., & Lee, S. S. (2008) · Biotechnology Progress · doi:10.1021/bp049815s · Cited by 199 · cited 1×
“Other environmental factors such as pH and osmolality are also known to impact cell growth and productivity (Monteil et al., 2016; Zhu et al., 2005).”
BackgroundEffects of temperature shift on cell cycle, apoptosis and nucleotide pools in CHO cell batch cultues
Moore, A., Mercer, J., Dutina, G., Donahue, C. J., Bauer, K. D., Mather, J. P., Etcheverry, T., & Ryll, T. (1997) · Cytotechnology · doi:10.1023/a:1007919921991 · Cited by 191
Carvell, J. P., & Dowd, J. E. (2006) · Cytotechnology · doi:10.1007/s10616-005-3974-x · Cited by 184
Allison, G., Cain, Y. T., Cooney, C., Garcia, T., Bizjak, T. G., Holte, O., Jagota, N., Komas, B., Korakianiti, E., Kourti, D., et al. (2015) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24324 · Cited by 181
Regulatory Perspectives on Continuous Pharmaceutical Manufacturing: Moving From Theory to Practice
Nasr, M. M., Krumme, M., Matsuda, Y., Trout, B. L., Badman, C., Mascia, S., Cooney, C. L., Jensen, K. D., Florence, A. J., Johnston, C. A., et al. (2017) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2017.06.015 · Cited by 180
Guidelines to cell engineering for monoclonal antibody production
Rita Costa, A., Elisa Rodrigues, M., Henriques, M., Azeredo, J., & Oliveira, R. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2009.10.002 · Cited by 178 · cited 1×
“The areas where the most significant advances have been registered in recent years include: cell metabolism, cell cycle control, protein secretion, apoptosis and glycosylation regulation (Arden and Betenbaugh, 2004; Costa et al., 2009; Fan et al., 2013; Krampe and Al-Rubeai, 2010; Lim et al., 2010).”
Backgroundvan Beers, M. M. C., & Bardor, M. (2012) · Biotechnology Journal · doi:10.1002/biot.201200065 · Cited by 172
Bioreactor productivity and media cost comparison for different intensified cell culture processes
Xu, S., Gavin, J., Jiang, R., & Chen, H. (2017) · Biotechnology Progress · doi:10.1002/btpr.2415 · Cited by 164
Whelan, J., Craven, S., & Glennon, B. (2012) · Biotechnology Progress · doi:10.1002/btpr.1590 · Cited by 159 · cited 1×
“Process parameters such as glucose, glutamate, glutamine, lactate and ammonium concentrations, total cell density (TCD), and viable cell density were monitored in fed-batch processes (Abu-Absi et al., 2011; Whelan et al., 2012).”
MethodImpact of Glycosylation on Effector Functions of Therapeutic IgG
Abès, R., & Teillaud, J. (2010) · Pharmaceuticals · doi:10.3390/ph3010146 · Cited by 156
Engineering mammalian cells in bioprocessing – current achievements and future perspectives
Lim, Y., Wong, N. S. C., Lee, Y. Y., Ku, S. C. Y., Wong, D. C. F., & Yap, M. G. S. (2010) · Biotechnology and Applied Biochemistry · doi:10.1042/ba20090363 · Cited by 156
Perfusion seed cultures improve biopharmaceutical fed‐batch production capacity and product quality
Yang, W. C., Lü, J., Kwiatkowski, C., Yuan, H., Kshirsagar, R., Ryll, T., & Huang, Y. (2014) · Biotechnology Progress · doi:10.1002/btpr.1884 · Cited by 156
Jesus, M. J. D., Girard, P., Bourgeois, M., Baumgartner, G., Jacko, B., Amstutz, H., & Wurm, F. M. (2003) · Biochemical Engineering Journal · doi:10.1016/s1369-703x(03)00180-3 · Cited by 154
Clincke, M., Mölleryd, C., Samani, P. K., Lindskog, E. K., Fäldt, E., Walsh, K., & Chotteau, V. (2013) · Biotechnology Progress · doi:10.1002/btpr.1703 · Cited by 152
Karst, D. J., Serra, E., Villiger, T. K., Soos, M., & Morbidelli, M. (2016) · Biochemical Engineering Journal · doi:10.1016/j.bej.2016.02.003 · Cited by 151
Self-citationBerry, B. N., Dobrowsky, T. M., Timson, R. C., Kshirsagar, R., Ryll, T., & Wiltberger, K. (2015) · Biotechnology Progress · doi:10.1002/btpr.2205 · Cited by 150
Steinebach, F., Müller‐Späth, T., & Morbidelli, M. (2016) · Biotechnology Journal · doi:10.1002/biot.201500354 · Cited by 147
Self-citationCell death in mammalian cell culture: molecular mechanisms and cell line engineering strategies
Krampe, B., & Al‐Rubeai, M. (2010) · Cytotechnology · doi:10.1007/s10616-010-9274-0 · Cited by 146
Grillberger, L., Kreil, T. R., Nasr, S., & Reiter, M. (2009) · Biotechnology Journal · doi:10.1002/biot.200800241 · Cited by 144
Advanced microscale bioreactor system: a representative scale-down model for bench-top bioreactors
Hsu, W.-T., Aulakh, R. P. S., Traul, D. L., & Yuk, I. H. Y. (2012) · Cytotechnology · doi:10.1007/s10616-012-9446-1 · Cited by 143
Technological progresses in monoclonal antibody production systems
Rodrigues, M. E., Costa, A. R., Henriques, M., Azeredo, J., & Oliveira, R. (2009) · Biotechnology Progress · doi:10.1002/btpr.348 · Cited by 142
Process performance and product quality in an integrated continuous antibody production process
Karst, D. J., Steinebach, F., Šoóš, M., & Morbidelli, M. (2016) · Biotechnology and Bioengineering · doi:10.1002/bit.26069 · Cited by 142
Self-citationComparison of batch and continuous multi‐column protein A capture processes by optimal design
Baur, D., Angarita, M., Müller‐Späth, T., Steinebach, F., & Morbidelli, M. (2016) · Biotechnology Journal · doi:10.1002/biot.201500481 · Cited by 140
Self-citationLee, H., Boccazzi, P., Ram, R. J., & Sinskey, A. J. (2006) · Lab on a Chip · doi:10.1039/b608014f · Cited by 133
Continuous integrated manufacturing of therapeutic proteins
Karst, D. J., Steinebach, F., & Morbidelli, M. (2018) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2017.12.015 · Cited by 133
Self-citationAhn, W. S., Jeon, J., Jeong, Y., Lee, S. J., & Yoon, S. K. (2008) · Biotechnology and Bioengineering · doi:10.1002/bit.22006 · Cited by 132
Al‐Rubeai, M., Emery, A. N., Chalder, S. M., & Jan, D. C.-H. (1992) · Cytotechnology · doi:10.1007/bf02521735 · Cited by 129
Design and operation of a continuous integrated monoclonal antibody production process
Steinebach, F., Ulmer, N., Wolf, M., Decker, L., Schneider, V., Wälchli, R., Karst, D. J., Souquet, J., & Morbidelli, M. (2017) · Biotechnology Progress · doi:10.1002/btpr.2522 · Cited by 129
Self-citationOpel, C. F., Li, J., & Amanullah, A. (2010) · Biotechnology Progress · doi:10.1002/btpr.425 · Cited by 127
Wang, S., Godfrey, S., Ravikrishnan, J., Lin, H. C., Vogel, J. H., & Coffman, J. (2017) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2017.01.020 · Cited by 127
In-situ microscopy: Online process monitoring of mammalian cell cultures
Joeris, K., Frerichs, J.-G., Konstantinov, K., & Scheper, T. H. (2002) · Cytotechnology · doi:10.1023/a:1021170502775 · Cited by 125
Eukaryotic Expression Systems: A Comparison
Geisse, S., Gram, H., Kleuser, B., & Kocher, H. P. (1996) · Protein Expression and Purification · doi:10.1006/prep.1996.0101 · Cited by 125
Wurm, F. M., & Hacker, D. L. (2011) · Nature Biotechnology · doi:10.1038/nbt.1943 · Cited by 122
The “Push-to-Low” Approach for Optimization of High-Density Perfusion Cultures of Animal Cells
Konstantinov, K., Goudar, C. T., Ng, M. R. A. V., Meneses, R., Thrift, J., Chuppa, S., Matanguihan, C., Michaels, J., & Naveh, D. (2006) · Advances in biochemical engineering, biotechnology · doi:10.1007/10_016 · Cited by 120
A Single-use Strategy to Enable Manufacturing of Affordable Biologics
Jacquemart, R., Vandersluis, M., Zhao, M., Sukhija, K., Sidhu, N., & Stout, J. (2016) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2016.06.007 · Cited by 119
Yang, W. C., Minkler, D. F., Kshirsagar, R., Ryll, T., & Huang, Y. (2015) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2015.10.009 · Cited by 118
Lee, K. S., Boccazzi, P., Sinskey, A. J., & Ram, R. J. (2011) · Lab on a Chip · doi:10.1039/c1lc20019d · Cited by 113
Du, Z., Treiber, D., McCarter, J. D., Fomina‐Yadlin, D., Saleem, R. A., McCoy, R. E., Zhang, Y., Tharmalingam, T., Leith, M., Follstad, B. D., et al. (2015) · Biotechnology and Bioengineering · doi:10.1002/bit.25332 · Cited by 113
Baur, D., Angarita, M., Müller‐Späth, T., & Morbidelli, M. (2015) · Biotechnology Journal · doi:10.1002/biot.201500223 · Cited by 110
Self-citationCharge heterogeneity: Basic antibody charge variants with increased binding to Fc receptors
Hintersteiner, B., Lingg, N., Zhang, P., Woen, S., Hoi, K. M., Stranner, S., Wiederkum, S., Mutschlechner, O., Schuster, M., Loibner, H., et al. (2016) · mAbs · doi:10.1080/19420862.2016.1225642 · Cited by 109
Generic Raman‐based calibration models enabling real‐time monitoring of cell culture bioreactors
Mehdizadeh, H., Lauri, D., Karry, K. M., Moshgbar, M., Procopio‐Melino, R., & Drapeau, D. (2015) · Biotechnology Progress · doi:10.1002/btpr.2079 · Cited by 108
Chartrain, M. M., & Chu, L. (2008) · Current Pharmaceutical Biotechnology · doi:10.2174/138920108786786367 · Cited by 108
Model based adaptive control of a continuous capture process for monoclonal antibodies production
Steinebach, F., Angarita, M., Karst, D. J., Müller‐Späth, T., & Morbidelli, M. (2016) · Journal of Chromatography A · doi:10.1016/j.chroma.2016.03.014 · Cited by 108
Self-citationHow does mild hypothermia affect monoclonal antibody glycosylation?
Sou, S. N., Sellick, C., Lee, K., Mason, A., Kyriakopoulos, S., Polizzi, K. M., & Kontoravdi, C. (2015) · Biotechnology and Bioengineering · doi:10.1002/bit.25524 · Cited by 107
Microwell engineering characterization for mammalian cell culture process development
Barrett, T. A., Wu, A., Zhang, H., Levy, M. S., & Lye, G. J. (2009) · Biotechnology and Bioengineering · doi:10.1002/bit.22531 · Cited by 102
Real-time biomass-concentration monitoring in animal-cell cultures
Konstantinov, K., Chuppa, S. L., Sajan, E., Tsai, Y.-S., Yoon, S., & Golini, F. (1994) · Trends in biotechnology · doi:10.1016/0167-7799(94)90049-3 · Cited by 101
High-density mammalian cell cultures in stirred-tank bioreactor without external pH control
Xu, S., & Chen, H. (2016) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2016.06.019 · Cited by 99
Wulhfard, S., Baldi, L., Hacker, D. L., & Wurm, F. M. (2010) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2010.05.003 · Cited by 99
Karst, D. J., Scibona, E., Serra, E., Bielser, J., Souquet, J., Stettler, M., Broly, H., Šoóš, M., Morbidelli, M., & Villiger, T. K. (2017) · Biotechnology and Bioengineering · doi:10.1002/bit.26315 · Cited by 99
Self-citationOptimizing capacity utilization by large scale 3000 L perfusion in seed train bioreactors
Pohlscheidt, M., Jacobs, M., Wolf, S., Thiele, J., Jockwer, A., Gabelsberger, J., Jenzsch, M., Tebbe, H., & Burg, J. (2012) · Biotechnology Progress · doi:10.1002/btpr.1672 · Cited by 98
Bunnak, P., Allmendinger, R., Ramasamy, S. V., Lettieri, P., & Titchener-Hooker, N. J. (2016) · Biotechnology Progress · doi:10.1002/btpr.2323 · Cited by 97
Hiller, G. W., Ovalle, A. M., Gagnon, M., Curran, M., & Wang, W. (2017) · Biotechnology and Bioengineering · doi:10.1002/bit.26259 · Cited by 94
Ducommun, P., Kadouri, A., von Stockar, U., & Marison, I. W. (2001) · Biotechnology and Bioengineering · doi:10.1002/bit.1197 · Cited by 93
Microfluidic Cell Retention Device for Perfusion of Mammalian Suspension Culture
Kwon, T., Prentice, H. L., Oliveira, J. D., Madziva, N., Warkiani, M. E., Hamel, J. P., & Han, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-06949-8 · Cited by 92
Yoon, S., Hwang, S. O., & Lee, G. M. (2004) · Biotechnology Progress · doi:10.1021/bp049847f · Cited by 88
Park, J. H., Noh, S. M., Woo, J. R., Kim, J. W., & Lee, G. M. (2016) · Biotechnology Journal · doi:10.1002/biot.201500327 · Cited by 81 · cited 3×
“Valeric acid, which is much cheaper than chemicals used in this context, was reported to increase mAb productivity in a fed-batch process without impacting quality attributes (Park et al., 2015).”
BackgroundA high-throughput media design approach for high performance mammalian fed-batch cultures
Rouiller, Y., Périlleux, A., Collet, N., Jordan, M., Stettler, M., & Broly, H. (2013) · mAbs · doi:10.4161/mabs.23942 · Cited by 81
Self-citationUnderstanding and modeling alternating tangential flow filtration for perfusion cell culture
Kelly, W. J., Scully, J. E. C., Zhang, D., Feng, G., Lavengood, M., Condon, J., Knighton, J., & Bhatia, R. (2014) · Biotechnology Progress · doi:10.1002/btpr.1953 · Cited by 81
Bareither, R., Bargh, N., Oakeshott, R., Watts, K. S., & Pollard, D. J. (2013) · Biotechnology and Bioengineering · doi:10.1002/bit.24978 · Cited by 81
Davey, C. L., Davey, H. M., Kell, D. B., & Todd, R. W. (1993) · Analytica Chimica Acta · doi:10.1016/0003-2670(93)85078-x · Cited by 80
Lin, H. C., Leighty, R. W., Godfrey, S., & Wang, S. B. (2017) · Biotechnology Progress · doi:10.1002/btpr.2472 · Cited by 80
Tailoring recombinant protein quality by rational media design
Brühlmann, D., Jordan, M., Hemberger, J., Sauer, M., Stettler, M., & Broly, H. (2015) · Biotechnology Progress · doi:10.1002/btpr.2089 · Cited by 76
Self-citationDowd, J. E., Jubb, A., Kwok, K. E., & Piret, J. M. (2003) · Cytotechnology · doi:10.1023/a:1026192228471 · Cited by 74
Vergara, M., Becerra, S., Berríos, J., Osses, N., Reyes, J. G., Rodríguez‐Moyá, M., González, R., & Altamirano, C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093865 · Cited by 70
Development and implementation of a perfusion‐based high cell density cell banking process
Tao, Y., Shih, J., Sinacore, M., Ryll, T., & Yusuf‐Makagiansar, H. (2011) · Biotechnology Progress · doi:10.1002/btpr.599 · Cited by 66
Cell culture medium improvement by rigorous shuffling of components using media blending
Jordan, M., Voisard, D., Berthoud, A., Tercier, L., Kleuser, B., Baer, G., & Broly, H. (2012) · Cytotechnology · doi:10.1007/s10616-012-9462-1 · Cited by 64
Self-citationKarst, D. J., Steinhoff, R., Kopp, M. R. G., Serra, E., Šoóš, M., Zenobi, R., & Morbidelli, M. (2016) · Biotechnology Progress · doi:10.1002/btpr.2421 · Cited by 61
Self-citationContinuous Bioprocessing and Perfusion: Wider Adoption Coming as Bioprocessing Matures
Langer, E. S. (2014) · BioProcessing Journal · doi:10.12665/j131.langer · Cited by 60
Ansorge, S., Esteban, G., & Schmid, G. (2010) · Cytotechnology · doi:10.1007/s10616-010-9267-z · Cited by 59
Gomez, N. V., Ambhaikar, M., Zhang, L., Huang, C., Barkhordarian, H., Lull, J., & Gutierrez, C. (2016) · Biotechnology Progress · doi:10.1002/btpr.2418 · Cited by 57
Enhancement of productivity of recombinant α-amidating enzyme by low temperature culture
Furukawa, K., & Ohsuye, K. (1999) · Cytotechnology · doi:10.1023/a:1008059803038 · Cited by 56
Controlling the time evolution of mAb N‐linked glycosylation, Part I: Microbioreactor experiments
Villiger, T. K., Roulet, A., Périlleux, A., Stettler, M., Broly, H., Morbidelli, M., & Šoóš, M. (2016) · Biotechnology Progress · doi:10.1002/btpr.2305 · Cited by 52
Self-citationMicrofluidic tools toward industrial biotechnology
Oliveira, A. F., Pessoa, A. C. S. N., Bastos, R. G., & de la Torre, L. G. (2016) · Biotechnology Progress · doi:10.1002/btpr.2350 · Cited by 52
Continuous Biopharmaceutical Processes: Chromatography, Bioconjugation, and Protein Stability
Pfister, D., Nicoud, L., & Morbidelli, M. (2018) · Cambridge University Press eBooks · doi:10.1017/9781108332897 · Cited by 52
Self-citationA new seed-train expansion method for recombinant mammalian cell lines
Heidemann, R., Mered, M., Wang, D. Q., Gardner, B., Zhang, C., Michaels, J. D., Henzler, H., Abbas, N., & Konstantinov, K. (2002) · Cytotechnology · doi:10.1023/a:1021114300958 · Cited by 51
Meuwly, F., Weber, U., Ziegler, T. R., Gervais, A., Mastrangeli, R., Crisci, C., Rossi, M., Bernard, A., von Stockar, U., & Kadouri, A. (2005) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2005.10.013 · Cited by 50
Development and application of a high-throughput platform for perfusion-based cell culture processes
Villiger-Oberbek, A., Yang, Y., Zhou, W., & Yang, J. (2015) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2015.06.428 · Cited by 47
Seth, G., Hamilton, R. W., Stapp, T. R., Zheng, L., Meier, A., Petty, K., Leung, S., & Chary, S. (2012) · Biotechnology and Bioengineering · doi:10.1002/bit.24808 · Cited by 47
Pentanoic Acid, a Novel Protein Synthesis Stimulant for Chinese Hamster Ovary(CHO) Cells.
Liu, C., Chu, I., & Hwang, S. (2001) · Journal of Bioscience and Bioengineering · doi:10.1016/s1389-1723(01)80114-6 · Cited by 45
Clincke, M., Mölleryd, C., Zhang, Y., Lindskog, E. K., Walsh, K., & Chotteau, V. (2011) · BMC Proceedings · doi:10.1186/1753-6561-5-s8-p105 · Cited by 44
Rouiller, Y., Bielser, J., Brühlmann, D., Jordan, M., Broly, H., & Stettler, M. (2015) · Biotechnology Progress · doi:10.1002/btpr.2186 · Cited by 43
Self-citationHecklau, C., Pering, S., Seibel, R., Schnellbaecher, A., Wehsling, M., Eichhorn, T., Hagen, J. V., & Zimmer, A. (2016) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2015.11.022 · Cited by 42 · cited 1×
“, sulfocysteine and phosphotyrosine sodium salts) and sustain similar cell culture performance (Hecklau et al., 2016; Zimmer et al., 2014).”
BackgroundBrühlmann, D., Sokolov, M., Butté, A., Sauer, M., Hemberger, J., Souquet, J., Broly, H., & Jordan, M. (2017) · Biotechnology and Bioengineering · doi:10.1002/bit.26269 · Cited by 42
Self-citationFed‐batch microbioreactor platform for scale down and analysis of a plasmid DNA production process
Bower, D. M., Lee, K. S., Ram, R. J., & Prather, K. L. J. (2012) · Biotechnology and Bioengineering · doi:10.1002/bit.24498 · Cited by 41
Sokolov, M., Ritscher, J., MacKinnon, N., Bielser, J., Brühlmann, D., Rothenhaüsler, D., Thanei, G., Šoóš, M., Stettler, M., Souquet, J., et al. (2016) · Biotechnology Progress · doi:10.1002/btpr.2374 · Cited by 40
Self-citationHenry, O., Kwok, E., & Piret, J. M. (2008) · Biotechnology Progress · doi:10.1002/btpr.17 · Cited by 39
Spearman, M. A., Chan, S., Jung, V., Kowbel, V., de Mendoza, M. S. C., Miranda, V., & Butler, M. (2016) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2016.04.031 · Cited by 38
A perfusion-capable microfluidic bioreactor for assessing microbial heterologous protein production
Mozdzierz, N. J., Love, K. R., Lee, K. S., Lee, H., Shah, K., Ram, R. J., & Love, J. C. (2015) · Lab on a Chip · doi:10.1039/c5lc00443h · Cited by 36
Fan, L., Frye, C. C., & Racher, A. J. (2013) · Pharmaceutical Bioprocessing · doi:10.4155/pbp.13.56 · Cited by 35
Deschênes, J., Desbiens, A., Perrier, M., & Kamen, A. (2006) · Asia-Pacific Journal of Chemical Engineering · doi:10.1002/apj.10 · Cited by 34
Coronel, J., Klausing, S., Heinrich, C., Noll, T., Figueredo‐Cardero, A., & Castilho, L. R. (2016) · Biochemical Engineering Journal · doi:10.1016/j.bej.2016.06.031 · Cited by 34
Impact of Pluronic® F68 on hollow fiber filter-based perfusion culture performance
Xu, S., Jiang, R., Chen, Y., Wang, F., & Chen, H. H. (2017) · Bioprocess and Biosystems Engineering · doi:10.1007/s00449-017-1790-2 · Cited by 32
Considerations in the early development of biosimilar products
Li, E. C., Abbas, R., Jacobs, I. A., & Yin, D. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2014.12.017 · Cited by 30
Factors that determine stability of highly concentrated chemically defined production media
McCoy, R. E., Costa, N. A., & Morris, A. E. (2015) · Biotechnology Progress · doi:10.1002/btpr.2047 · Cited by 30
Impact of apoptosis on the on-line measured dielectric properties of CHO cells
Zalai, D., Tobak, T., & Putics, Á. (2015) · Bioprocess and Biosystems Engineering · doi:10.1007/s00449-015-1479-3 · Cited by 29
Zimmer, A., Mueller, R., Wehsling, M., Schnellbaecher, A., & von Hagen, J. (2014) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2014.06.026 · Cited by 29
Karst, D. J., Steinhoff, R., Kopp, M. R. G., Šoóš, M., Zenobi, R., & Morbidelli, M. (2017) · Biotechnology Progress · doi:10.1002/btpr.2539 · Cited by 29
Self-citationHilbold, N.-J., LeSaout, X., Valéry, E., Muhr, L., Souquet, J., Lamproye, A., & Broly, H. (2017) · Biotechnology Progress · doi:10.1002/btpr.2465 · Cited by 25
Self-citationMonteil, D., Juvet, V., Paz, J., Moniatte, M., Baldi, L., Hacker, D., & Wurm, F. (2016) · Biotechnology progress (Print) · doi:10.1002/btpr.2328 · Cited by 23
Continuous bioprocessing: The real thing this time?
Farid, S. S., Thompson, B., & Davidson, A. (2014) · mAbs · doi:10.4161/mabs.36151 · Cited by 20
Bosco, B., Paillet, C., Amadeo, I., Mauro, L., Ortí, E., & Forno, G. (2017) · Biotechnology Progress · doi:10.1002/btpr.2487 · Cited by 16
Cited by
Tripathi, N. K., & Shrivastava, A. (2019) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00420 · Cited by 575
Modern Sensor Tools and Techniques for Monitoring, Controlling, and Improving Cell Culture Processes
Reyes, S. J., Durocher, Y., Pham, P. L., & Henry, O. (2022) · Processes · doi:10.3390/pr10020189 · Cited by 130
Recommendations for Comparison of Productivity Between Fed‐Batch and Perfusion Processes
Bausch, M., Schultheiss, C., & Sieck, J. B. (2019) · Biotechnology Journal · doi:10.1002/biot.201700721 · Cited by 73
Perfusion culture of Chinese Hamster Ovary cells for bioprocessing applications
MacDonald, M. A., Nöbel, M., Roche Recinos, D., Martínez, V. S., Schulz, B. L., Howard, C. B., Baker, K., Shave, E., Lee, Y. Y., Marcellin, E., et al. (2022) · Critical Reviews in Biotechnology · doi:10.1080/07388551.2021.1998821 · Cited by 55
Yilmaz, D., Mehdizadeh, H., Navarro, D., Shehzad, A., O'Connor, M., & McCormick, P. (2020) · Biotechnology Progress · doi:10.1002/btpr.2947 · Cited by 51
Metadata
- Authors
- Bielser, J.-M., Wolf, M., Souquet, J., Broly, H., & Morbidelli, M.
- Venue
- Biotechnology Advances
- Publisher
- Elsevier BV
- Published
- 2018-07
- Volume
- 36
- Issue
- 4
- Pages
- 1328-1340
- ISSN
- 0734-9750 (ISSN-L)
- OpenAlex
- W2800956912
- Cited by
- 263
- References
- 129
- FWCI
- 7.69
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.